A detailed history of Elo Mutual Pension Insurance CO transactions in Incyte Corp stock. As of the latest transaction made, Elo Mutual Pension Insurance CO holds 14,462 shares of INCY stock, worth $1.11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,462
Previous 17,163 15.74%
Holding current value
$1.11 Million
Previous $1.04 Million 8.17%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $154,848 - $185,315
-2,701 Reduced 15.74%
14,462 $955,000
Q2 2024

Aug 12, 2024

SELL
$51.18 - $63.75 $12,436 - $15,491
-243 Reduced 1.4%
17,163 $1.04 Million
Q1 2024

May 13, 2024

BUY
$56.55 - $66.59 $43,882 - $51,673
776 Added 4.67%
17,406 $991,000
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $42,353 - $52,122
812 Added 5.13%
16,630 $1.04 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $13,287 - $15,163
230 Added 1.48%
15,818 $914,000
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $25,538 - $31,638
419 Added 2.76%
15,588 $970,000
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $41,997 - $51,433
598 Added 4.1%
15,169 $1.1 Million
Q4 2022

Feb 13, 2023

BUY
$67.18 - $84.11 $31,977 - $40,036
476 Added 3.38%
14,571 $1.17 Million
Q3 2022

Nov 10, 2022

SELL
$66.18 - $82.86 $44,472 - $55,681
-672 Reduced 4.55%
14,095 $939,000
Q1 2022

May 10, 2022

BUY
$66.02 - $79.71 $57,107 - $68,949
865 Added 6.22%
14,767 $1.17 Million
Q4 2021

Feb 09, 2022

BUY
$63.34 - $74.11 $43,577 - $50,987
688 Added 5.21%
13,902 $1.02 Million
Q2 2021

Aug 13, 2021

SELL
$79.87 - $87.53 $17,172 - $18,818
-215 Reduced 1.6%
13,214 $1.11 Million
Q1 2021

May 12, 2021

BUY
$76.02 - $100.5 $16,116 - $21,306
212 Added 1.6%
13,429 $1.09 Million
Q4 2020

Feb 11, 2021

BUY
$80.74 - $97.7 $1.07 Million - $1.29 Million
13,217 New
13,217 $1.15 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Elo Mutual Pension Insurance CO Portfolio

Follow Elo Mutual Pension Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elo Mutual Pension Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Elo Mutual Pension Insurance CO with notifications on news.